- SP Plus Corporation stock price today and history
SP Plus Corporation (SP) stock prices updated...
Please, Signup (Login) to subscribe or trade (demo)
SP Plus Corporation stock price
SP Plus Corporation latest news:
BRIEF-SP Plus Corp Posts Q4 Adjusted Earnings Per Share $0.40
* SP PLUS CORPORATION ANNOUNCES FOURTH QUARTER AND FULL-YEAR
Bristol-Myers's stock surges toward 18-month high after Morgan Stanley turns bullish
Bristol-Myers Squibb Co.'s stock shot up 4.1% toward an 18-month high in morning trade Thursday, after Morgan Stanley turned bullish on the drugmaker, for the first time in 18 months, citing "compelling" immuno-oncology growth prospects. Analyst David Risinger raised his rating to overweight, after being at equal weight since Aug. 5, 2016, and boosted his stock price target to $78 from $63. Risinger said after he "dug deeper" into the company's release of the phase 3 Checkmate-227 study of Opdivo plus Yervoy combination versus chemotherapy, his investment thesis has changed: "We have greater confidence that Bristol's Opdivo + Yervoy combination regimen can play a meaningful role in first-line lung cancer, which is the largest cancer market." The stock was on track to close at the highest level since Aug. 4, 2016. It has now run up 11.5% over the past three months, while the SPDR Health Care Select Sector ETF has gained 4.3% and the S&P 500 has climbed 5.6%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Antares Pharma, Amag Pharma shares soar premarket after FDA approves auto injector
Shares of Antares Pharma Inc. and Amag Pharmaceuticals soared in premarket trade Thursday, after Amag said the U.S. Food and Drug Administration has approved their Makena subcutaneous auto injector drug-device combination product, a ready-to-administer treatment to reduce the risk of preterm birth in women who are pregnant with one baby and who spontaneously delivered one preterm baby in the past. Under the terms of a deal agreed between the two companies in 2014, Amag will make and supply the drug product to Antares, which will manufacture the device, assemble and package it for sale to Amag at cost plus margin. Antares will receive high single digit to low double digit royalties on sales and be eligible for milestone payments. Antares shares soared 26%, while Amag shares were up 19%. S&P 500 futures were up 0.5%. Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Copyright Royalty Board decision to raise songwriter streaming rates leaves out majority of Pandora's business
The Copyright Royalty Board of the U.S. Library of Congress decided over the weekend to bump up the amount streaming services like Spotify and Apple Inc. have to pay songwriters for interactive streaming by roughly 44% over the next five years. Under the new ruling, streaming companies will have to pay 15.1% of their revenue to songwriters and music publishers, up from 10.5%. In a note to clients on Monday, Raymond James analyst Justin Patterson wrote that the decision won't affect advertising, which is the majority of Pandora Media Inc.'s revenue. Pandora shares rose nearly 5% during intraday trade on Monday. "The [Copyright Royalty Board's] decision to increase interactive rates affects only Pandora's interactive services _ Pandora Plus and Premium," Patterson wrote. "Pandora's ad-supported service, which we project as about 77% of 2017 revenue is classified as radio and is not affected by this decision." Interactive services are ones where listeners are streaming music on-demand. Pandora shares have declined more than 66% in the last 12 months, while the S&P 500 index is up close to 25% and the Dow Jones Industrial Average is up more than 32%.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
Japan Display in talks over $1.8 bln-plus investment from China firms - Kyodo
* Japan Display (JNNDF) shares jump 7 pct. * BOE Technology, Tianma among potential investors - Kyodo. * Japan Display (JNNDF) needs cash to invest in OLED technology. Cash-strapped Japan Display Inc (JNNDF) is discussing an investment of more than 200 billion yen from three Chinese panel makers including BOE Technology Group Co, Kyodo News reported.
UPDATE 2-Japan Display in talks over $1.8 bln-plus investment from China firms - Kyodo
* Japan Display needs cash to invest in OLED technology
(Adds details on smartphone makers' OLED shift, company
Analysis: GOP's tea party promises dashed in tax cut embrace
The tea party class of 2010 vowed to usher in a new era for the Republican Party, one where conservatives clamoring for fiscal discipline would roll back government spending to rein in trillion-plus budget deficits.
Span-America Medical Systems, Inc.SPAN
Spanish Broadcasting System, Inc.SBSA
SPAR Group, Inc.SGRP
Spark Energy, Inc.SPKE
Spark Therapeutics, Inc.ONCE
Spartan Motors, Inc.SPAR
Spectrum Pharmaceuticals, Inc.SPPI
Speed Commerce, Inc.SPDC
Sphere 3D Corp.ANY